Glimibrit MV 2mg/500mg/0.2mg Tablet
Marketer
Elbrit Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimibrit MV 2mg/500mg/0.2mg Tablet
Diabetol Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes mellitus. This medication helps regulate blood glucose in diabetic patients. Diabetol Trio should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a broader treatment plan encompassing diet, exercise, and weight management as recommended by your doctor; lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Be prepared to manage this by maintaining regular meals and carrying a fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Glimibrit MV 2mg/500mg/0.2mg Tablet
Managing Type 2 diabetes
Major Benefits of Glimibrit MV 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Glimibrit MV 2mg/500mg/0.2mg tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Glimibrit MV 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimibrit MV 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimibrit MV 2mg/500mg/0.2mg Tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
How Glimibrit MV 2mg/500mg/0.2mg Tablet works:
Each Glimibrit MV tablet (2mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimibrit MV 2mg/500mg/0.2mg tablets is dangerous.
PregnancyCONSULT YOUR DOCTOR
Use of Glimibrit MV 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimibrit MV 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of Glimibrit MV 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Seek medical advice before use. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimibrit MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. In those with mild to moderate liver disease, initiate treatment with a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimibrit MV 2mg/500mg/0.2mg Tablet :
Should you forget to take your Glimibrit MV 2mg/500mg/0.2mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimibrit MV 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |
3,018 People bought this recently